Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine as a Primary Series for Adults Aged 18 and OlderPRNewsWire • 09/13/22
Novavax, Inc. (NVAX) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)Seeking Alpha • 09/12/22
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Use as a Booster for Adults Aged 18 and OlderPRNewsWire • 09/12/22
Novavax (NVAX) Down 29.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/07/22
Swissmedic Authorizes Novavax Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 Through 17 and as a Booster in Adults Aged 18 and OlderPRNewsWire • 09/02/22
Novavax Nuvaxovid™ COVID-19 Vaccine Recommended by CHMP for Expanded Conditional Marketing Authorization in the European Union as a Booster for Adults Aged 18 and OlderPRNewsWire • 09/01/22
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through 17PRNewsWire • 08/26/22